I-Mab Biopharma (IMAB) Misses Q2 EPS by 3c

I-Mab Biopharma (NASDAQ: IMAB) reported Q2 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on I-Mab Biopharma (IMAB) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Walmart shares fall despite earnings beat
• Simmons First National Corp (SFNC) Declares $0.215 Quarterly Dividend; 3.7% Yield